Nesiritide for Treatment of Heart Failure Patients
Guidance for claims that CMS will deny coverage of nesiritide for the treatment of chronic heart failure in Medicare beneficiaries. CMS has determined that all other indications for the use of nesiritide not otherwise indicated as non-covered above are left to local contractor discretion.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: April 07, 2006
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.